Cat.No：GM-26839AB
Product：Anti-H_SLC39A6 hIgG1 Antibody(Ladiratuzumab)
Cat.No：GM-26839AB
Product：Anti-H_SLC39A6 hIgG1 Antibody(Ladiratuzumab)
GM-26839AB-10 10 μg
GM-26839AB-100 100 μg
GM-26839AB-1000 1mg
Species Reactivity Human; Cynomolgus
Clone Ladiratuzumab
Source/Isotype Monoclonal human IgG1, κ
Application Flow Cytometry
Specificity Detects SLC39A6
Gene SLC39A6
Other Names LIV-1; LIV1; ZIP6
Gene ID 25800(human), 101926643(cynomolgus)
Background SLC39A6 is also known as LIV-1, ZIP-6 and Zinc transporter ZIP6. May act as a zinc-influx transporter. Highly expressed in the breast, prostate, placenta, kidney, pituitary, and corpus callosum. Weakly expressed in heart and intestine. Also highly expressed in cells derived from an adenocarcinoma of the cervix and lung carcinoma. The LIV-1 protein has also been implicated in certain cancerous conditions, e.g., breast cancer and prostate cancer. The detection of LIV-1 is associated with estrogen receptor-positive breast cancer, and the metastatic spread of these cancers to the regional lymph nodes.
Storage Store at 2-8℃ short term (1-2 weeks).Store at ≤ -20℃ long term. Avoid repeated freeze-thaw.
Formulation Phosphate-buffered solution, pH 7.2.
Endotoxin < 1 EU/mg, determined by LAL gel clotting assay
Cat.No：GM-26839AB
Product：Anti-H_SLC39A6 hIgG1 Antibody(Ladiratuzumab)
GM-26839AB-10 10 μg
GM-26839AB-100 100 μg
GM-26839AB-1000 1mg
Species Reactivity Human; Cynomolgus
Clone Ladiratuzumab
Source/Isotype Monoclonal human IgG1, κ
Application Flow Cytometry
Specificity Detects SLC39A6
Gene SLC39A6
Other Names LIV-1; LIV1; ZIP6
Gene ID 25800(human), 101926643(cynomolgus)
Background SLC39A6 is also known as LIV-1, ZIP-6 and Zinc transporter ZIP6. May act as a zinc-influx transporter. Highly expressed in the breast, prostate, placenta, kidney, pituitary, and corpus callosum. Weakly expressed in heart and intestine. Also highly expressed in cells derived from an adenocarcinoma of the cervix and lung carcinoma. The LIV-1 protein has also been implicated in certain cancerous conditions, e.g., breast cancer and prostate cancer. The detection of LIV-1 is associated with estrogen receptor-positive breast cancer, and the metastatic spread of these cancers to the regional lymph nodes.
Storage Store at 2-8℃ short term (1-2 weeks).Store at ≤ -20℃ long term. Avoid repeated freeze-thaw.
Formulation Phosphate-buffered solution, pH 7.2.
Endotoxin < 1 EU/mg, determined by LAL gel clotting assay
